Mink Therapeutics
| Mink Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
22 of 92
Related slides by other companies
Immix Biopharma
Investor Presentation
November 2023
potential to disrupt the oncology and immunology categories | Immix Biopharma
Cytek
Investor Day
June 2022
mapping the landscape of the lung in pneumococcal pneumonia nature antigen presentation by epithelial cell function and regulates barrier immunity i | Cytek
Alkermes
Investor Day
March 2021
immune modulation in oncology based on engineered have pleiotropic effects and can act on every phase of the cancer immunity cycle alkermes is focusing on based therapies designed to increase visibility of tumor cells to immune system increase tumor killing potential of and cells mutation fusion remove suppressive signals in the tumor modern based drugs need a high degree of engineering to reduce side effects improve enhance efficacy natural killer journal of cancer cycle | Alkermes
Apexigen
Investor Presentation
September 2022
single dose of turns cold tumor hot data presented at some | Apexigen
Other recent decks by Mink Therapeutics
See all presentations (2 decks)
IPO
October 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io